Subclinical Hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-Thyroxine
- 1 June 1987
- journal article
- research article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 82 (6), 1167-1170
- https://doi.org/10.1016/0002-9343(87)90219-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.BMJ, 1985
- Thyroxine replacement treatment: clinical judgment or biochemical control?BMJ, 1985
- Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis".BMJ, 1984
- Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine.BMJ, 1984
- Elevated serum thyroxine concentration in patients receiving “replacement” doses of levothyroxineJournal of Endocrinological Investigation, 1982
- Thyrotropin-Releasing Hormone Is Not the Sole Physiologic Mediator of Prolactin Release during SucklingNew England Journal of Medicine, 1974
- Suppression of Pituitary TSH Secretion in the Patient with a Hyperfunctioning Thyroid NoduleJCI Insight, 1973
- Hyperthyroidism and calcium metabolismClinics in Endocrinology and Metabolism, 1973
- Bony Manifestations of ThyrotoxicosisOrthopedic Clinics of North America, 1972
- SERUM TRI-IODOTHYRONINE UPTAKE USING COATED CHARCOAL IN THE ASSESSMENT OF THYROID FUNCTIONJournal of Endocrinology, 1968